BIOMARKERS AS PREDICTORS OF STRUCTURAL DAMAGE IN RHEUMATOID ARTHRITIS

The RA BIODAM Program is an international collaborative network of 50 sites in 10 countries – a multi-centre, multi-national longitudinal observational study (LOS) – that explores the several soluble biomarkers for predicting structural damage in RA patients. The aim is the development of prognostic models in RA. developed by Dr. Walter P. Maksymowych.

Scroll to Top